This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: HF-pEF

Book review

June 2015 Br J Cardiol 2015;22:67–8

Book review

Hannah ZR McConkey, Kevin Leong, Fu Siong Ng, Graham Cole

Abstract

Author: Khavandi A Publisher: Oxford University Press, 2014 ISBN: 978-0-19-965490-1, Price: £59.99 The authors have been very successful at publishing the first knowledge-based assessment (KBA) revision aid – a well structured book which, over 32 chapters, comprehensively provides an excellent overview of the UK national curriculum and closely follows the European curriculum, making it an ideal preparation tool for the European Exam in Cardiology. The wealth of information in each chapter makes it relevant to both those in training but also consultants who may wish to use it as a quick reference book or to help with teaching.  It has most

| Full text
News from the 7th Annual Scientific Meeting of the Cardiorenal Forum

December 2012 Br J Cardiol 2013;20:20–1 Online First

News from the 7th Annual Scientific Meeting of the Cardiorenal Forum

Abstract

Introduction As doctors and scientists we are accustomed to breaking down problems and simplifying complex pathology in order to focus our management and identify possible targets for future therapies. The pathophysiology of cardiorenal disease is no different but, as yet, attempts to elucidate the complex interaction between heart and kidneys has failed. Although cardiac and renal disease are often diagnosed together, it is clear that a straightforward causal relationship does not exist. Disease in either serves as a risk factor for disease in the other and perpetuates the progression of that disease, but why this is so is unclear. Whilst th

| Full text

November 2012 Br J Cardiol 2012;19:152

News from the ESC Congress 2012

BJCardio Staff

Abstract

WOEST: aspirin not required for stent patients on oral anticoagulants  A strategy of using clopidogrel as a single antiplatelet drug for patients receiving a drug-eluting stent who are also taking an oral anticoagulant appears safe and can reduce bleeding, the results of the WOEST study suggest. How to treat patients on anticoagulation when they receive a stent is fraught with difficulty as giving the normal dual antiplatelet therapy with aspirin and clopidogrel means they will be taking three anti-clotting agents which could increase bleeding complications to a dangerous level. But no randomised clinical trials have ever investigated whethe

| Full text
Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now